FRIDAY, June 7, 2019 (HealthDay News) — Stimulus control therapy and sleep restriction therapy are viable single-component treatments for chronic insomnia, according to a study published in the June issue of Worldviews on Evidence-Based Nursing.
Souraya Sidani, Ph.D., from the Daphne Cockwell School of Nursing at Ryerson University in Toronto, and colleagues compared the effect of three single-component therapies (sleep education and hygiene, stimulus control therapy, or sleep restriction therapy) and one multiple-component therapy on short-term sleep outcomes among 517 persons with chronic insomnia.
The researchers found that sleep education and hygiene was least effective, while stimulus control therapy, sleep restriction therapy, and multiple-component therapy were moderately effective. For perceived insomnia severity and some sleep parameters, stimulus control therapy and sleep restriction therapy demonstrated slightly higher remission rates than multiple-component therapy.
“Single-component insomnia treatment may be more convenient to implement in the primary care setting due to the reduced number of treatment recommendations compared to multiple-component therapy,” the authors write.
Copyright © 2019 HealthDay. All rights reserved.